<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>İşte 5 uygun etiket: **Hepatosellüler Karsinom Tedavisi &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/iste-5-uygun-etiket-hepatoselluler-karsinom-tedavisi/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 17 Nov 2025 15:28:07 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>İşte 5 uygun etiket: **Hepatosellüler Karsinom Tedavisi &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>New 2024 Guidelines on Managing Liver Injury from Targeted Therapies and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma</title>
		<link>https://bioengineer.org/new-2024-guidelines-on-managing-liver-injury-from-targeted-therapies-and-immune-checkpoint-inhibitors-in-hepatocellular-carcinoma/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 17 Nov 2025 15:27:57 +0000</pubDate>
				<category><![CDATA[Cancer]]></category>
		<category><![CDATA[Hedefe Yönelik Tedavi Yan Etkileri]]></category>
		<category><![CDATA[İlaç Kaynaklı Karaciğer Hasarı]]></category>
		<category><![CDATA[İmmün Kontrol Noktası İnhibitörleri]]></category>
		<category><![CDATA[İşte 5 uygun etiket: **Hepatosellüler Karsinom Tedavisi]]></category>
		<category><![CDATA[Karaciğer Hasarı Kılavuzu** **Kısa açıklama:** 1. **Hepatosellüler K]]></category>
		<guid isPermaLink="false">https://bioengineer.org/new-2024-guidelines-on-managing-liver-injury-from-targeted-therapies-and-immune-checkpoint-inhibitors-in-hepatocellular-carcinoma/</guid>

					<description><![CDATA[The treatment of hepatocellular carcinoma (HCC) has seen revolutionary advancements with the introduction of molecular targeted therapies and immune checkpoint inhibitors (ICIs). These systemic treatments have extended survival and improved outcomes for patients with intermediate to advanced stages of HCC. However, the promise of these agents is tempered by their liability to induce liver injury, [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">297872</post-id>	</item>
	</channel>
</rss>
